Meeting of the National Vaccine Advisory Committee Vaccine Safety Working Group, 3046 [E9-973]

Download as PDF 3046 Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices the burden increase as it exists now is based on current data updating the number of MAS Schedule contractors. B. Annual Reporting Burden Number of Respondents: 18,000. Total Annual Responses: 36,000. Average hours per response: 2 hours. Total Burden Hours: 72,000. Obtaining copies of proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat (VPR), 1800 F Street, NW., Room 4041, Washington, DC 20405, telephone (202) 501–4755. Please cite OMB Control No. 3090–0235, Price Reductions Clause, in all correspondence. Dated: January 12, 2009 Al Matera, Director, Office of Acquisition Policy. [FR Doc. E9–868 Filed 1–15–09; 8:45 am] BILLING CODE 6820–61–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Vaccine Safety Working Group mstockstill on PROD1PC66 with NOTICES AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice of meeting. SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) Vaccine Safety Working Group will hold a meeting. The meeting is open to the public. Preregistration is required for both public attendance and comment. Audio conferencing will be available for listening only. DATES: The meeting will be held on February 4, 2009, from 8 a.m. to 12:30 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 800, 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Kirsten Vannice, National Vaccine Program Office, Department of Health and Human Services, Room 443–H, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 260–1165; e-mail: kirsten.vannice@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health VerDate Nov<24>2008 19:02 Jan 15, 2009 Jkt 217001 Service Act (42 U.S.C. Section 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. The NVAC Vaccine Safety Working Group was established to (1) undertake and coordinate a scientific review of the draft Centers for Disease Control and Prevention (CDC) Immunization Safety Office (ISO) Scientific Agenda, and (2) review the current vaccine safety system. On February 4, 2009, the NVAC Vaccine Safety Working Group will hear and discuss the results of the community activities that occurred to obtain public input on the ISO Scientific Agenda, and a summary of the written comments solicited in a previous Federal Register notice from January 2, 2009 (for more information on submitting written comments, please see below). This information will inform the Working Group and the NVAC recommendations on the ISO scientific agenda. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person above at least one week prior to the meeting. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Pre-registration is required for both public attendance and comment. Individuals who would like to submit written statements to the NVAC Vaccine Safety Working Group should refer to instructions on the Federal Register Notice Docket ID fr02ja09–30, January 2, 2009 (Volume 74, Number 1) pages 107–108 (https:// edocket.access.gpo.gov/2009/E831196.htm). Any members of the public who wish to have printed material distributed to NVAC Vaccine Safety Working Group members should submit materials to the Executive Secretary, NVAC, through the contact person listed above prior to close of business January 30, 2009. Audio-conferencing will be available for listening only. The call-in PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 number is as follows: 888–469–2187, Participant Passcode: 2973732. Dated: January 13, 2009. Bruce Gellin, Deputy Assistant Secretary for Health Director, National Vaccine Program Office. [FR Doc. E9–973 Filed 1–15–09; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30 Day—09–08AX] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project Sexually Transmitted Disease (STD) Morbidity Surveillance—New— National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The CDC is responsible for the reporting and dissemination of nationally notifiable STD morbidity information for prevention and control purposes in collaboration with state and local health departments. Recent changes in sexually transmitted disease (STD) epidemiology in the United States indicate that the existing passive surveillance for STD does not include all the elements needed in order to control and prevent STDs in the U.S. Towards that end, CDC is proposing a new electronic information collection called STD Morbidity Surveillance that will include information on laboratory confirmation of syphilis infection and risk behaviors of persons infected with syphilis and other STDs. Physicians and other providers collect demographic, risk, and clinical (including laboratory) information from persons diagnosed with notifiable STDs during a clinical encounter or counseling session. The E:\FR\FM\16JAN1.SGM 16JAN1

Agencies

[Federal Register Volume 74, Number 11 (Friday, January 16, 2009)]
[Notices]
[Page 3046]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-973]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee Vaccine Safety 
Working Group

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) Vaccine Safety 
Working Group will hold a meeting. The meeting is open to the public. 
Pre-registration is required for both public attendance and comment. 
Audio conferencing will be available for listening only.

DATES: The meeting will be held on February 4, 2009, from 8 a.m. to 
12:30 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800, 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Kirsten Vannice, National Vaccine 
Program Office, Department of Health and Human Services, Room 443-H, 
Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, 
DC 20201. Phone: (202) 690-5566; Fax: (202) 260-1165; e-mail: 
kirsten.vannice@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health 
and Human Services was mandated to establish the National Vaccine 
Program to achieve optimal prevention of human infectious diseases 
through immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    The NVAC Vaccine Safety Working Group was established to (1) 
undertake and coordinate a scientific review of the draft Centers for 
Disease Control and Prevention (CDC) Immunization Safety Office (ISO) 
Scientific Agenda, and (2) review the current vaccine safety system.
    On February 4, 2009, the NVAC Vaccine Safety Working Group will 
hear and discuss the results of the community activities that occurred 
to obtain public input on the ISO Scientific Agenda, and a summary of 
the written comments solicited in a previous Federal Register notice 
from January 2, 2009 (for more information on submitting written 
comments, please see below). This information will inform the Working 
Group and the NVAC recommendations on the ISO scientific agenda.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the contact person above at least one week prior to the meeting. 
Members of the public will have the opportunity to provide comments at 
the meeting. Public comment will be limited to five minutes per 
speaker. Pre-registration is required for both public attendance and 
comment. Individuals who would like to submit written statements to the 
NVAC Vaccine Safety Working Group should refer to instructions on the 
Federal Register Notice Docket ID fr02ja09-30, January 2, 2009 (Volume 
74, Number 1) pages 107-108 (https://edocket.access.gpo.gov/2009/E8-31196.htm). Any members of the public who wish to have printed material 
distributed to NVAC Vaccine Safety Working Group members should submit 
materials to the Executive Secretary, NVAC, through the contact person 
listed above prior to close of business January 30, 2009. Audio-
conferencing will be available for listening only. The call-in number 
is as follows: 888-469-2187, Participant Passcode: 2973732.

    Dated: January 13, 2009.
Bruce Gellin,
Deputy Assistant Secretary for Health Director, National Vaccine 
Program Office.
 [FR Doc. E9-973 Filed 1-15-09; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.